At a glance
- Originator Novo Nordisk
- Class Anti-ischaemics; Neuroprotectants; Small molecules
- Mechanism of Action Adenosine A1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Stroke
Most Recent Events
- 04 Nov 1999 New profile
- 04 Nov 1999 Preclinical development for Stroke in Denmark (Unknown route)